TBPH: Theravance Quarterly Revenue Growth

Graphic logo of theravance.com (TBPH)

High FDA regulatory barriers and patent protection for organ-selective technologies create a sustainable market moat for Theravance Biopharma (TBPH). The magnitude of quarterly revenue growth helps track operational dynamics, where the value -20.80 represents the most recent figure. Theravance Biopharma (TBPH) relies on risk-free royalties from global bestsellers to ensure net cash flow while expanding its portfolio with therapies for respiratory and infectious pathologies.

TBPH Theravance Biopharma Inc Quarterly Revenue Increase (07/04/2022 - 10/10/2026)

Theravance Biopharma, Inc. - analytical breakdowns and key metrics (TBPH)

- stock price and consensus target price:
Analysis of all company metrics:TBPH - Theravance Biopharma, Inc.
Flagship merchandise of theravance.com

For Theravance Biopharma (TBPH), which develops high-precision drugs with organ-specific action, commercial success depends on the market adoption of innovations. This quarterly revenue growth metric measures the percentage change in sales volume relative to the previous period, reflecting the speed of intellectual property monetization and operational resilience. Positive quarterly revenue growth confirms the effectiveness of the expansion strategy and the business's ability to generate cash flow to cover debt obligations.

Direct competitors

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth LQDA (Liquidia Technologies)|Quarterly Revenue Growth Galapagos GLPG|ANI Pharmaceuticals Inc - Quarterly Revenue Growth|MNKD (MannKind Corp.) - Sales Growth QoQ|AMPH: Quarterly Revenue Growth|PCRX (Pacira BioSciences) - Revenue Growth QoQ|Revenue Growth QoQ ARS Pharmaceuticals Inc|Quarterly Revenue Growth Rate Aquestive Pharma AQST|Quarterly Revenue Growth SCPH|Sales Change QoQ TECX|Revenue Growth QoQ tonixpharma.com TNXP|SXTC (SXT China) - Revenue Dynamics QoQ|Eupraxia Pharmaceuticals - Quarterly Revenue Growth|Quarterly Sales Growth Rate BioHarvest Sciences Inc. BHST|EXOZ: Quarterly Revenue Growth|Oramed (ORMP) - Quarterly Revenue Growth|ENTX (Entera Bio) - Quarterly Revenue Growth|ipatherapeutics.com (HYFT) - Quarterly Sales Growth Rate|Quarterly Revenue Growth ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Quarterly Revenue Increase|Revenue Growth QoQ Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Quarterly Revenue Growth Rate|TELO: Quarterly Sales Growth|Quarterly Sales Growth Rate Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Revenue Growth QoQ|RLYB - Quarterly Sales Growth Rate|Revenue Growth QoQ Lexaria Bioscience|Pulmatrix Corp - Revenue Dynamics QoQ|Revenue Growth QoQ ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth QoQ|Quarterly Revenue Growth LYRA (Lyra Therapeutics Inc.)|Quarterly Sales Growth Rate Impact BioMedical (IBO)|TNF Pharmaceuticals - Quarterly Revenue Growth|Quarterly Revenue Growth Rate cbdMD Inc.|PainReform Ltd. (PRFX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Altamira Therapeutics (CYTO)|Revenue Growth QoQ Lipella Pharmaceuticals, Inc.|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)